sb 202190 has been researched along with Constriction, Pathological in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, S | 1 |
| Ren, J | 1 |
| Zhang, CE | 1 |
| Treskov, I | 1 |
| Wang, Y | 1 |
| Muslin, AJ | 1 |
1 other study available for sb 202190 and Constriction, Pathological
| Article | Year |
|---|---|
Role of 14-3-3-mediated p38 mitogen-activated protein kinase inhibition in cardiac myocyte survival.
Topics: 14-3-3 Proteins; Animals; Aorta; Apoptosis; Cardiomyopathy, Dilated; Cell Survival; Constriction, Pa | 2003 |